Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Mamoncillo (Melicoccus bijugatus) is a tropical fruit rich in polyphenolic compounds, vitamin C, and dietary fiber that collectively support immune function, antioxidant defense, and cardiovascular health through modulation of oxidative stress pathways and enhancement of white blood cell activity. Notably, the Sapindaceae family to which mamoncillo belongs contains methylenecyclopropylglycine (MCPG), a hypoglycin-related compound whose metabolites have been detected in biological systems (Bochnia et al., PLoS One, 2019; PMID 30721263), underscoring the importance of understanding both the benefits and toxicological profile of this fruit's bioactive constituents.
Reported Benefits (Provisional)
Origin & History
Mamoncillo (Melicoccus bijugatus), also known as Spanish lime or quenepa, is a small, round fruit native to the tropical regions of northern South America, Central America, and the Caribbean. It grows in clusters on trees, featuring a green, leathery skin that encases a tangy-sweet pulp. This highly nutritious fruit is valued for its hydrating properties and rich micronutrient profile, making it a functional food for overall wellness.
Research Narrative (Provisional)
Research on mamoncillo and its Sapindaceae relatives has identified methylenecyclopropylglycine (MCPG) as a notable bioactive compound; Bochnia et al. (2019) published in PLoS One (PMID 30721263) confirmed the detection of MCPG metabolites in biological tissues, highlighting the pharmacological relevance of compounds found in this fruit family. Preliminary in vitro studies on Melicoccus bijugatus pulp extracts have demonstrated significant free radical scavenging activity attributable to flavonoids including catechin, epicatechin, and quercetin glycosides. Nutritional analyses confirm that mamoncillo provides approximately 60 mg of vitamin C per 100 g of pulp, along with appreciable potassium (approximately 135 mg/100 g), supporting its traditional use for immune and cardiovascular health. However, rigorous human clinical trials specifically evaluating mamoncillo's health outcomes remain notably absent from the literature, and most evidence derives from compositional analyses and in vitro bioactivity assays.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber: Supports digestive health and blood sugar regulation. - Vitamin C: Potent antioxidant, essential for immune function and collagen synthesis. - B Vitamins (Thiamine, Riboflavin, Pyridoxine): Crucial for energy metabolism and neurological function. - Potassium: Regulates blood pressure and maintains electrolyte balance. - Calcium, Phosphorus, Magnesium: Support bone strength, muscle function, and nerve signaling. - Iron: Essential for red blood cell production and oxygen transport. - Polyphenols, Carotenoids, Flavonoids: Powerful antioxidants that reduce oxidative stress. - Tryptophan: Essential amino acid supporting serotonin production and mood.
Reported Mechanism (Provisional)
Mamoncillo's polyphenolic compounds—including catechins, proanthocyanidins, and quercetin glycosides—exert antioxidant effects by donating hydrogen atoms to neutralize reactive oxygen species (ROS) and by chelating transition metal ions (Fe²⁺, Cu²⁺) that catalyze Fenton reactions. The fruit's vitamin C (ascorbic acid) enhances immune function by stimulating neutrophil chemotaxis, phagocytosis, and interferon production, while also regenerating oxidized vitamin E (α-tocopherol) at cell membranes. Polyphenolic constituents have demonstrated in vitro inhibition of acetylcholinesterase (AChE), potentially prolonging acetylcholine availability at cholinergic synapses and supporting neurocognitive signaling. Potassium content contributes to cardiovascular regulation by promoting vasodilation through activation of endothelial Na⁺/K⁺-ATPase pumps and modulating renin-angiotensin-aldosterone system (RAAS) activity to reduce blood pressure.
Clinical Narrative (Provisional)
Current clinical evidence for mamoncillo is extremely limited, with most research consisting of preliminary in vitro and animal studies. One study identified acetylcholinesterase modulation by M. bijugatus extracts, though specific concentrations, study duration, and sample sizes were not reported. Human clinical trials evaluating mamoncillo's immune, cardiovascular, or cognitive benefits are lacking. The evidence base remains insufficient to establish definitive therapeutic efficacy or optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.